Molecular Imaging: Page 474

PET/CT play complementary roles in osseous lesion detection

By Jonathan S. Batchelor

CHICAGO - Hybrid imaging with PET/CT for osseous lymphomatous deposits allows physicians to take advantage of the strengths of each modality -- the morphological capabilities of CT and functional capabilities of PET help identify the metabolically active bony lesions in lymphoma patients, according to a study presented Monday afternoon at the 2006 RSNA conference.

November 27, 2006

Dilon enters Asian market

By AuntMinnie.com staff writers

Gamma camera developer Dilon Technologies of Newport News, VA, has expanded its reach to the Asian market with a distribution agreement for its Dilon 6800 gamma camera with radiology products distributor Hongwoo Medico of South Korea.

November 27, 2006

PET, CT CAD scheme differentiates benign from malignant lung nodules

By Eric Barnes

CHICAGO - PET has a well-established role for distinguishing benign from malignant lung nodules when CT is inconclusive. Now radiologists have tapped the power of artificial neural networks (ANNs) for a computer-aided detection (CAD) scheme that determines whether PET results can improve the performance of CT-based lung CAD.

November 27, 2006

Spectrum Dynamics receives 510(k) for D-SPECT

By AuntMinnie.com staff writers

Israeli gamma camera developer Spectrum Dynamics of Tirat Hacarmel has received clearance from the U.S. Food and Drug Administration for its D-SPECT cardiac system with BroadView imaging technology.

November 26, 2006

Philips RSNA highlights include MRI, DR, SPECT introductions

By Wayne Forrest, Brian Casey

CHICAGO - New product introductions in MRI, digital radiography (DR), and SPECT are among the highlights in the RSNA booth of Andover, MA-based Philips Medical Systems. The company is also touting enhancements in its CT, ultrasound, PACS, and speech recognition business.

November 26, 2006

Abdominopelvic PET profits from forced diuresis

By Jonathan S. Batchelor

PET studies of the abdomen and pelvis have the potential for identifying and staging a variety of malignancies. But trying to image this area with F-18 FDG, the only radiopharmaceutical reimbursed in the U.S. for noncardiac PET, is compromised by its accumulation in the gastrointestinal tract and urinary tracer activity. Researchers from Switzerland have recently developed a procedure to overcome this limitation -- forced diuresis with parenteral hydration.

November 23, 2006

ART repurchases debentures

By AuntMinnie.com staff writers

Canadian optical molecular imaging developer Advanced Research Technologies (ART) reported that it has entered into agreements to repurchase its entire outstanding senior secured convertible debentures.

November 20, 2006

AuntMinnie.com Molecular Imaging Insider

By Jonathan S. Batchelor

November 19, 2006

IsoRay sales triple in fiscal Q1

By AuntMinnie.com staff writers

Medical isotope developer IsoRay of Richland, WA, saw revenues more than triple in the first quarter of the company's 2007 fiscal year, although the company's operating loss for the period grew as well.

November 14, 2006

SNM survey shows NMT satisfaction

By AuntMinnie.com staff writers

According to a survey conducted last year by SNM, certified nuclear medicine technologists (CNMTs) enjoy their jobs, find their salaries near the top of the scale for professions with similar educational requirements, and represent a gender-diverse group.

November 14, 2006

Molecular imaging rides roller coaster in 2006

By Jonathan S. Batchelor

November 14, 2006

Spectrum Dynamics

By Jonathan S. Batchelor

Israeli gamma camera developer Spectrum Dynamics of Tirat Hacarmel will be at the 2006 RSNA conference in Chicago later this month to demonstrate the capabilities of its D-SPECT nuclear cardiology system.

November 14, 2006

Previous Page

Page 474 of 615

Next Page